Literature DB >> 34014282

Universal Genetic Testing to Identify Pathogenic Germline Variants in Patients With Cancer-Reply.

Edward D Esplin1, N Jewel Samadder2.   

Abstract

Entities:  

Mesh:

Year:  2021        PMID: 34014282     DOI: 10.1001/jamaoncol.2021.1012

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN: 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  2 in total

1.  Clinical Utility of Universal Germline Genetic Testing for Patients With Breast Cancer.

Authors:  Pat W Whitworth; Peter D Beitsch; Rakesh Patel; Barry Rosen; Gia Compagnoni; Paul L Baron; Rache Simmons; Eric A Brown; Linsey Gold; Dennis Holmes; Linda Ann Smith; Michael Kinney; Ian Grady; Patricia Clark; Karen Barbosa; Samuel Lyons; Lee Riley; Cynara Coomer; Lisa Curcio; Antonio Ruiz; Sadia Khan; Heather MacDonald; Kevin Hughes; Mary Kay Hardwick; Brandie Heald; Sandra B Munro; Sarah M Nielsen; Edward D Esplin
Journal:  JAMA Netw Open       Date:  2022-09-01

2.  Universal Germline Genetic Testing for Hereditary Cancer Syndromes in Patients With Solid Tumor Cancer.

Authors:  Edward D Esplin; Sarah M Nielsen; Sara L Bristow; Judy E Garber; Heather Hampel; Huma Q Rana; N Jewel Samadder; Neal D Shore; Robert L Nussbaum
Journal:  JCO Precis Oncol       Date:  2022-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.